Index NDX, S&P 500 P/E 18.87 EPS (ttm) 4.34 Insider Own 0.27% Shs Outstand 456.96M Perf Week -0.63%
Market Cap 37.48B Forward P/E 15.59 EPS next Y 5.26 Insider Trans -0.52% Shs Float 456.08M Perf Month -10.03%
Income 1.99B PEG 2.03 EPS next Q 0.91 Inst Own 85.70% Short Float 2.21% Perf Quarter 6.30%
Sales 19.67B P/S 1.91 EPS this Y 4.80% Inst Trans 6.02% Short Ratio 3.42 Perf Half Y -9.57%
Book/sh 18.49 P/B 4.43 EPS next Y 11.69% ROA 6.08% Short Interest 10.07M Perf Year -9.84%
Cash/sh 6.32 P/C 12.97 EPS next 5Y 9.31% ROE 25.60% 52W Range 74.51 - 94.80 Perf YTD 4.82%
Dividend Est. 0.10 (0.12%) P/FCF 24.18 EPS past 5Y 5.31% ROI 12.30% 52W High -13.56% Beta 1.32
Dividend TTM 0.09 (0.11%) Quick Ratio 0.79 Sales past 5Y 3.43% Gross Margin 41.44% 52W Low 9.98% ATR (14) 2.02
Dividend Ex-Date Jan 14, 2025 Current Ratio 1.00 EPS Y/Y TTM 43.28% Oper. Margin 14.67% RSI (14) 37.01 Volatility 1.50% 2.57%
Employees 53000 Debt/Eq 1.11 Sales Y/Y TTM 0.61% Profit Margin 10.13% Recom 1.60 Target Price 102.88
Option/Short Yes / Yes LT Debt/Eq 0.92 EPS Q/Q 78.52% Payout 2.88% Rel Volume 0.58 Prev Close 81.49
Sales Surprise -0.23% EPS Surprise 14.78% Sales Q/Q 2.17% Earnings Feb 13 BMO Avg Volume 2.95M Price 81.95
SMA20 -3.37% SMA50 -5.60% SMA200 -2.90% Trades
Volume 992,299 Change 0.56%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-25 Upgrade Goldman
Neutral → Buy
$85 → $100
Jan-08-25 Upgrade Jefferies
Hold → Buy
$95 → $103
Sep-26-24 Downgrade UBS
Neutral → Sell
$84 → $74
Sep-18-24 Upgrade BTIG Research
Neutral → Buy
$100
Sep-09-24 Initiated JP Morgan
Neutral
$90
Aug-06-24 Initiated Stifel
Buy
$100
May-30-24 Initiated Goldman
Neutral
$87
Feb-15-24 Initiated HSBC Securities
Buy
$100
Feb-12-24 Upgrade UBS
Sell → Neutral
$66 → $88
Nov-30-23 Initiated Jefferies
Hold
$80
Nov-27-23 Downgrade UBS
Neutral → Sell
$86 → $66
Sep-19-23 Initiated Citigroup
Buy
$82
Aug-25-23 Initiated Argus
Buy
$80
Aug-16-23 Initiated Wells Fargo
Overweight
$90
Jul-31-23 Initiated BofA Securities
Neutral
$82
Jun-27-23 Initiated Morgan Stanley
Equal-Weight
$76
May-16-23 Initiated Oppenheimer
Outperform
$97
Apr-26-23 Initiated UBS
Neutral
$86
Apr-19-23 Initiated Piper Sandler
Overweight
$95
Apr-10-23 Initiated BTIG Research
Neutral
Show Previous Ratings
Today 10:47AM
10:12AM
09:40AM
Mar-23-25 12:00PM
Mar-22-25 02:29PM
12:52PM
Loading…
Mar-20-25 12:52PM
08:00AM
05:10AM
04:45AM
Mar-19-25 12:54PM
Mar-18-25 04:05PM
Mar-17-25 09:01AM
Mar-04-25 07:01PM
09:00AM
Feb-27-25 02:00AM
08:00AM
Loading…
Feb-26-25 08:00AM
Feb-25-25 09:00AM
Feb-23-25 10:46AM
Feb-14-25 01:53PM
Feb-13-25 06:57PM
(Morningstar Research) +8.82%
06:20AM
Feb-11-25 09:00AM
Feb-10-25 09:00AM
Jan-31-25 03:00AM
Jan-29-25 08:04AM
07:30AM
Jan-28-25 08:00AM
Jan-22-25 04:05PM
(Investor's Business Daily)
03:46PM
(Investor's Business Daily)
12:00PM
(Investor's Business Daily)
10:53AM
Loading…
10:53AM
(Investor's Business Daily)
Jan-21-25 04:04PM
(Investor's Business Daily)
Jan-15-25 09:00AM
Jan-14-25 09:25AM
Jan-08-25 04:30PM
Jan-03-25 06:46AM
Dec-12-24 08:00AM
Dec-05-24 09:00AM
Dec-04-24 09:15AM
09:00AM
Dec-03-24 08:00AM
Dec-01-24 11:45PM
12:30PM
09:00AM
Nov-30-24 07:20AM
06:05AM
Nov-26-24 09:00AM
Nov-25-24 09:00AM
Nov-22-24 09:09AM
Nov-21-24 04:54PM
06:00AM
Nov-18-24 08:00AM
Nov-13-24 08:00AM
Nov-12-24 08:13PM
10:00AM
Nov-11-24 06:00AM
Nov-07-24 09:31PM
04:58PM
08:00AM
Nov-03-24 01:37PM
Oct-31-24 06:57AM
02:58AM
Oct-30-24 06:20AM
Oct-24-24 12:16PM
Oct-21-24 12:10PM
12:10PM
Oct-18-24 02:30PM
09:20AM
Oct-17-24 09:00AM
Oct-16-24 12:38PM
Oct-14-24 09:00AM
Oct-09-24 09:00AM
Oct-08-24 08:46AM
(Investor's Business Daily)
08:00AM
Oct-07-24 09:00AM
02:30AM
Oct-06-24 01:24PM
Sep-30-24 10:35AM
(The Wall Street Journal)
Sep-27-24 04:32PM
Sep-26-24 09:00AM
Sep-24-24 06:40PM
09:00AM
Sep-19-24 09:00AM
Sep-18-24 04:50PM
Sep-12-24 09:40PM
05:02PM
Aug-26-24 09:00AM
Aug-21-24 09:00AM
Aug-20-24 08:30AM
Aug-19-24 10:00AM
Aug-14-24 09:50AM
Aug-02-24 01:37PM
Jul-31-24 06:20AM
Jul-25-24 08:45AM
Jul-21-24 10:00AM
Jul-18-24 03:26AM
Jul-15-24 12:15PM
Jul-13-24 08:45PM
Jul-12-24 06:54AM
Jul-11-24 02:01PM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Advanced Visualization Solutions segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company's history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Newcomb George A. Chief Accounting Officer Feb 18 '25 Sale 92.54 2,000 185,080 7,462 Feb 19 04:07 PM Rott Roland CEO, Imaging Nov 05 '24 Option Exercise 40.40 13,275 536,310 37,573 Nov 06 05:53 PM Rott Roland CEO, Imaging Nov 06 '24 Sale 86.48 3,577 309,339 24,298 Nov 06 05:53 PM Roland Rott Officer Nov 06 '24 Proposed Sale 86.48 3,577 309,330 Nov 06 05:45 PM Philip Rackliffe Officer Nov 05 '24 Proposed Sale 87.63 900 78,870 Nov 05 05:22 PM Rackliffe Philip CEO, AVS Nov 05 '24 Sale 87.63 900 78,867 12,715 Nov 05 04:06 PM Stacherski Kenneth R. Ch. Supply Chain & Serv. Ofc. Aug 14 '24 Sale 83.22 19,008 1,581,846 38,541 Aug 15 04:45 PM Kenneth Stacherski Officer Aug 14 '24 Proposed Sale 82.74 19,008 1,572,774 Aug 14 05:57 PM Jan Makela Officer Aug 12 '24 Proposed Sale 83.20 33,096 2,753,587 Aug 12 04:58 PM Westrick Thomas J. CEO, Patient Care Solutions Aug 07 '24 Sale 80.78 2,750 222,145 17,509 Aug 07 06:18 PM Thomas Westrick Officer Aug 07 '24 Proposed Sale 80.78 2,750 222,146 Aug 07 05:30 PM Kass-Hout Taha Chief Technology Officer May 28 '24 Sale 78.70 3,300 259,710 67,300 May 29 04:05 PM Makela Jan CEO, Imaging May 15 '24 Option Exercise 74.35 66,955 4,978,229 130,303 May 15 07:15 PM Makela Jan CEO, Imaging May 13 '24 Option Exercise 63.51 20,227 1,284,617 83,575 May 15 07:15 PM Makela Jan CEO, Imaging May 15 '24 Sale 81.54 66,955 5,459,511 63,348 May 15 07:15 PM Makela Jan CEO, Imaging May 13 '24 Sale 81.57 20,227 1,649,916 63,348 May 15 07:15 PM Jimenez Frank R GC & Corporate Secretary May 01 '24 Buy 76.52 1,315 100,624 75,796 May 02 06:00 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
